ABEN GOLD CORP (ABM.CA) Fundamental Analysis & Valuation

TSX-V:ABM • CA00289A1093

Current stock price

0.16 CAD
0 (0%)
Last:

This ABM.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. ABM.CA Profitability Analysis

1.1 Basic Checks

  • ABM had negative earnings in the past year.
  • ABM had a negative operating cash flow in the past year.
  • In the past 5 years ABM always reported negative net income.
  • ABM had a negative operating cash flow in each of the past 5 years.
ABM.CA Yearly Net Income VS EBIT VS OCF VS FCFABM.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 2025 -1M -2M -3M -4M -5M

1.2 Ratios

  • ABM has a worse Return On Assets (-73.37%) than 70.70% of its industry peers.
  • The Return On Equity of ABM (-77.18%) is worse than 63.84% of its industry peers.
Industry RankSector Rank
ROA -73.37%
ROE -77.18%
ROIC N/A
ROA(3y)-28.37%
ROA(5y)-18.69%
ROE(3y)-29.78%
ROE(5y)-19.54%
ROIC(3y)N/A
ROIC(5y)N/A
ABM.CA Yearly ROA, ROE, ROICABM.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 2025 -20 -40 -60

1.3 Margins

  • ABM does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ABM.CA Yearly Profit, Operating, Gross MarginsABM.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 2025

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. ABM.CA Health Analysis

2.1 Basic Checks

  • The number of shares outstanding for ABM has been increased compared to 1 year ago.
  • The number of shares outstanding for ABM has been increased compared to 5 years ago.
  • Compared to 1 year ago, ABM has a worse debt to assets ratio.
ABM.CA Yearly Shares OutstandingABM.CA Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M
ABM.CA Yearly Total Debt VS Total AssetsABM.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 2025 5M 10M 15M

2.2 Solvency

  • ABM has an Altman-Z score of 0.30. This is a bad value and indicates that ABM is not financially healthy and even has some risk of bankruptcy.
  • With a Altman-Z score value of 0.30, ABM is not doing good in the industry: 60.60% of the companies in the same industry are doing better.
  • ABM has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 0.3
ROIC/WACCN/A
WACCN/A
ABM.CA Yearly LT Debt VS Equity VS FCFABM.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 2025 0 5M 10M

2.3 Liquidity

  • A Current Ratio of 1.56 indicates that ABM should not have too much problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 1.56, ABM is in line with its industry, outperforming 44.02% of the companies in the same industry.
  • ABM has a Quick Ratio of 1.56. This is a normal value and indicates that ABM is financially healthy and should not expect problems in meeting its short term obligations.
  • ABM has a Quick ratio of 1.56. This is comparable to the rest of the industry: ABM outperforms 46.38% of its industry peers.
Industry RankSector Rank
Current Ratio 1.56
Quick Ratio 1.56
ABM.CA Yearly Current Assets VS Current LiabilitesABM.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2025 500K 1M 1.5M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. ABM.CA Growth Analysis

3.1 Past

  • The earnings per share for ABM have decreased strongly by -806.03% in the last year.
EPS 1Y (TTM)-806.03%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%76.09%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocksShow best growing peers

0

4. ABM.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for ABM. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ABM.CA Price Earnings VS Forward Price EarningsABM.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ABM.CA Per share dataABM.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 -0.1 0.2 -0.2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ABM.CA Dividend Analysis

5.1 Amount

  • No dividends for ABM!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ABM.CA Fundamentals: All Metrics, Ratios and Statistics

ABEN GOLD CORP

TSX-V:ABM (4/24/2026, 7:00:00 PM)

0.16

0 (0%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)02-27
Earnings (Next)05-25
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners7%
Ins Owner ChangeN/A
Market Cap4.53M
Revenue(TTM)N/A
Net Income(TTM)-5.92M
Analysts80
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.59
P/tB 0.59
EV/EBITDA N/A
EPS(TTM)-0.26
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0
BVpS0.27
TBVpS0.27
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -73.37%
ROE -77.18%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-28.37%
ROA(5y)-18.69%
ROE(3y)-29.78%
ROE(5y)-19.54%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.56
Quick Ratio 1.56
Altman-Z 0.3
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-806.03%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%76.09%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y0.12%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y31.03%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y21.32%
OCF growth 3YN/A
OCF growth 5YN/A

ABEN GOLD CORP / ABM.CA Fundamental Analysis FAQ

What is the ChartMill fundamental rating of ABEN GOLD CORP (ABM.CA) stock?

ChartMill assigns a fundamental rating of 1 / 10 to ABM.CA.


What is the valuation status of ABEN GOLD CORP (ABM.CA) stock?

ChartMill assigns a valuation rating of 0 / 10 to ABEN GOLD CORP (ABM.CA). This can be considered as Overvalued.


Can you provide the profitability details for ABEN GOLD CORP?

ABEN GOLD CORP (ABM.CA) has a profitability rating of 0 / 10.


What is the financial health of ABEN GOLD CORP (ABM.CA) stock?

The financial health rating of ABEN GOLD CORP (ABM.CA) is 5 / 10.